Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Surkova, N. Shpakovskaya, O. Zalutskaya, M. Djusmikeeva (Minsk, Belarus). Role of cytokines in the immunopathogenesis of the MDR pulmonary tuberculosis. Eur Respir J 2008; 32: Suppl. 52, 2545

Member's Comments

No comment yet.

Related content which might interest you: Cytokines in pathogenesis of pulmonary tuberculosis Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011 Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 The role of leptin and TNF-alpha in pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 35s Year: 2004 Could pulmonary tuberculosis present without any inflammatory response? Source: Eur Respir J 2005; 26: Suppl. 49, 420s Year: 2005 Significance of circulating immune complexes in pulmonary tuberculosis Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007 Clinical utility of the interferon-gamma for the diagnosis of active pulmonary tuberculosis Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Endobrochites of specific genesis in patients with pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 201s Year: 2004 Characterization of the aetiological agent in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 12s Year: 2006 Atypical aspects of pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 507s Year: 2006 T-bet is augmented during the pathogenesis of pulmonary sarcoidosis Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009 Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Cytokine gene polymorphisms and mycobacterium tuberculosis: from infection to pulmonary disease Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006 Serum cytokines level can differentiate active pulmonary tuberculosis from latent TB Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Interrelation between mTB multi drug-resistance and cytokine activity in pulmonary TB patients and mTB virulence Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Intravenous ozon in MDR pulmonary tuberculosis Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Characteristics of the cases with primary multidrug resistance pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005 Treatment results of multidrug-resistant pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 11s Year: 2006 Lymphopenia and pulmonary tuberculosis Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Atypical pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012